Balanced Portfolio Update: Yancoal (YAL) Quarterly update
Yancoal has delivered their quarterly update overnight. This has seen the price rally to $5.75 (+19%)
Yancoal has delivered their quarterly update overnight. This has seen the price rally to $5.75 (+19%)
Pilbara is one of our favourites and has been a big winner for us over the last 3 years. Despite this the headwinds have become too great in the medium term with lithium prices falling 78% in the last 12 months.
Amid economic uncertainties, healthcare remains resilient, benefiting from consistent needs and innovation. This strategic move offers stability and growth potential in a fluctuating market.
Take Profit Telix Pharma (TLX) in our balanced portfolio, we will take half our allocation for a 15.8% profit as we see the overall market underperforming in the next couple of weeks.
With our Paladin holding a solid 20% in the money, we are recommending a 40% trim to the company specific play and switch to the broader and safer URNM ETF holding to remain involved in the Uranium/Nuclear power thematic.
Metallurgical and thermal coal producer New Hope is positioned well for long-term organic growth with strong relationships with existing international trading partners like Japan and the slow pace of the “green transition”
with the ASX200 underperforming the S&P 500 by the most in 18 months we are recommending a BUY of the leveraged long ASX200 and a short in the S&P500
Despite the geopolitical pressure, the Timor approval and WDS merger talk, STO has struggled to fund a bid. Conversely, the recent coal import numbers from China showed a 35% increase in coal imports
CSL continues to rally @ $281. Original position was 8% allocation. Today trim another 2% to take down to 4% allocation.
Add Telix Pharma (TLX) in our balanced portfolio, capitalizing on Telix’s innovative cancer treatment advancements and market potential.
The Nasdaq hedge is unlikely to work over the short-term as the thesis of the rate hiking cycle being finished, combined with the 70% occurrence of a “Christmas Rally”
Investing 1% of our portfolio allocation in PLS presents a compelling opportunity. PLS stands as the most shorted stock on the ASX, with a substantial 20.45% short interest. This indicates potential for a short squeeze, which could lead to a rapid price increase.